151 related articles for article (PubMed ID: 10340832)
21. Oleander poisoning: treatment with digoxin-specific Fab antibody fragments.
Shumaik GM; Wu AW; Ping AC
Ann Emerg Med; 1988 Jul; 17(7):732-5. PubMed ID: 3382077
[TBL] [Abstract][Full Text] [Related]
22. Treatment of foxglove extract poisoning with digoxin-specific Fab fragments.
Rich SA; Libera JM; Locke RJ
Ann Emerg Med; 1993 Dec; 22(12):1904-7. PubMed ID: 8239114
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic effects of the Fab fragment of digoxin antibody (digibind) in corticotropin (ACTH)-induced hypertension.
Li M; Wen C; Whitworth JA
Am J Hypertens; 1997 Mar; 10(3):332-6. PubMed ID: 9056691
[TBL] [Abstract][Full Text] [Related]
24. Changing characteristics of the TDx digoxin II assay in detecting bufadienolides in a traditional Chinese medicine: for better or worse?
Panesar NS; Chan KW; Law LK
Ther Drug Monit; 2005 Oct; 27(5):677-9. PubMed ID: 16175143
[TBL] [Abstract][Full Text] [Related]
25. Cardioactive steroid poisoning: a comparison of plant- and animal-derived compounds.
Barrueto F; Kirrane BM; Cotter BW; Hoffman RS; Nelson LS
J Med Toxicol; 2006 Dec; 2(4):152-5. PubMed ID: 18072135
[TBL] [Abstract][Full Text] [Related]
26. Review of clinical experience with digoxin immune Fab (ovine).
Smith TW
Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):1-6; discussion 33-4. PubMed ID: 1997014
[TBL] [Abstract][Full Text] [Related]
27. [Antidigoxin Fab-fragments in suicidal digoxin poisoning. Successful treatment of recurrent ventricular fibrillation].
Weller P; Peters U; Dickmanns HA; Hespe TH; Adam M; Allolio B; Smolarz A; Grabensee B
Dtsch Med Wochenschr; 1983 Sep; 108(38):1437-40. PubMed ID: 6884234
[TBL] [Abstract][Full Text] [Related]
28. Digoxin toxicity treated with Digibind.
Schakenbach L; Arft P
Crit Care Nurse; 1989 May; 9(5):16-22. PubMed ID: 2805742
[No Abstract] [Full Text] [Related]
29. Experience with digoxin immune Fab (ovine) in patients with renal impairment.
Wenger TL
Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):21-3; discussion 33-4. PubMed ID: 1997017
[TBL] [Abstract][Full Text] [Related]
30. Influence of assay methods on serum concentrations of digoxin during FAB fragment treatment.
Banner W; Bach P; Burk B; Freestone S; Gooch WM
J Toxicol Clin Toxicol; 1992; 30(2):259-67. PubMed ID: 1588675
[TBL] [Abstract][Full Text] [Related]
31. Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factor(s) from the venom of Bufo marinus toad.
Bagrov AY; Roukoyatkina NI; Fedorova OV; Pinaev AG; Ukhanova MV
Eur J Pharmacol; 1993 Apr; 234(2-3):165-72. PubMed ID: 8387009
[TBL] [Abstract][Full Text] [Related]
32. Digoxin and digoxin derivative induced arrhythmias: in vitro binding and in vivo abolition of arrhythmias by digoxin immune Fab (DIGIBAND).
Cambridge D; Morgan CR; Allen G
Cardiovasc Res; 1992 Sep; 26(9):906-11. PubMed ID: 1451168
[TBL] [Abstract][Full Text] [Related]
33. Recurrent digoxin overdose and treatment with digoxin-specific Fab antibody fragments.
Bosse GM; Pope TM
J Emerg Med; 1994; 12(2):179-85. PubMed ID: 8207153
[TBL] [Abstract][Full Text] [Related]
34. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children.
Woolf AD; Wenger T; Smith TW; Lovejoy FH
N Engl J Med; 1992 Jun; 326(26):1739-44. PubMed ID: 1594015
[TBL] [Abstract][Full Text] [Related]
35. Activated charcoal is more effective than equilibrium dialysis in removing Chinese medicines Chan Su and Dan Shen from serum and activated charcoal also prevents further absorption of these agents from G.I. tract in mice: monitoring the effect in clinical laboratory by measuring digoxin activity in serum.
Dasgupta A; Wahed A; Culton L; Olsen M; Wells A; Actor JK
Clin Chim Acta; 2002 Oct; 324(1-2):51-9. PubMed ID: 12204425
[TBL] [Abstract][Full Text] [Related]
36. Effects of digoxin-specific antibody Fab fragment (Digibind) on blood pressure and renal water-sodium metabolism in 5/6 reduced renal mass hypertensive rats.
Kaide J; Ura N; Torii T; Nakagawa M; Takada T; Shimamoto K
Am J Hypertens; 1999 Jun; 12(6):611-9. PubMed ID: 10371371
[TBL] [Abstract][Full Text] [Related]
37. Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study.
Hickey AR; Wenger TL; Carpenter VP; Tilson HH; Hlatky MA; Furberg CD; Kirkpatrick CH; Strauss HC; Smith TW
J Am Coll Cardiol; 1991 Mar; 17(3):590-8. PubMed ID: 1993775
[TBL] [Abstract][Full Text] [Related]
38. Electrophysiologic similarities of overdose between digoxin and bufadienolides found in a Chinese aphrodisiac.
Bressman M; Repplinger D; Slater W; Patt M
J Arrhythm; 2017 Feb; 33(1):76-78. PubMed ID: 28217235
[TBL] [Abstract][Full Text] [Related]
39. [The monitoring of plasma digoxin levels during acute digitalis poisoning treated with Fab anti-digoxin fragments].
Milani L; Bizzaro N; Sanson A
G Ital Cardiol; 1992 Jan; 22(1):97-101. PubMed ID: 1624074
[TBL] [Abstract][Full Text] [Related]
40. Monitoring serum digoxin concentrations during digoxin immune Fab therapy.
Ujhelyi MR; Colucci RD; Cummings DM; Green PJ; Robert S; Vlasses PH; Zarowitz BJ
DICP; 1991 Oct; 25(10):1047-9. PubMed ID: 1803787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
